Healthy Inc > Blog > Rheumatic fever prophylaxis dose
Posted on:

What is benzathine penicillin 1.2 million units used for?

Pharmaceutical Product Monograph: Benzathine Penicillin G (1.2 Million Units)

In the pharmaceutical industry, Benzathine Penicillin G is the ultra-long-acting, insoluble salt of Benzylpenicillin. As a pharmacist and manufacturer, I view this molecule as a “Sustained-Release Repository”—it is technically designed to create a “depot” in the muscle tissue that slowly releases penicillin into the bloodstream over 2 to 4 weeks.

At your WHO-GMP facility in Mumbai, Benzathine Penicillin 1.2 MIU is a critical SKU for Public Health Tenders, specifically for the eradication of Rheumatic Fever and Syphilis.

Therapeutic Profile: Primary Indications

The 1.2 Million Unit (MIU) dose is the global standard for prophylaxis and treatment of specific chronic bacterial infections.

IndicationClinical ContextTechnical Rationale
Rheumatic FeverSecondary ProphylaxisGold Standard. Prevents recurrent Group A Streptococcal infections that cause heart valve damage.
SyphilisPrimary/Secondary/LatentA single 1.2 MIU or 2.4 MIU dose is curative for early syphilis due to the sustained plasma levels.
Post-Streptococcal GNKidney ProtectionEradicates residual Streptococcus to prevent glomerulonephritis (kidney inflammation).
Yaws & BejelTropical DiseasesUsed in mass drug administration (MDA) programs to eradicate endemic treponematoses.

Mechanism: The “Depot” Sustained-Release

Benzathine Penicillin works by significantly extending the half-life of the penicillin molecule:

Low Solubility: The benzathine salt is nearly insoluble in water. When injected deep into the muscle, it forms a physical “depot.”

Slow Dissolution: The drug slowly dissolves into the interstitial fluid at a constant rate.

Bactericidal Action: Once in the blood, it acts like regular Benzylpenicillin by binding to Penicillin-Binding Proteins (PBPs), inhibiting cell wall synthesis and causing osmotic lysis of the bacteria.

The Pharmacist’s “Technical Warning”

  • Strictly IM Only: As a pharmacist, I must emphasize that this drug must never be given IV. Because it is a thick suspension, accidental intravenous injection can cause Embolia Cutis Medicamentosa (Hoigné’s Syndrome) or permanent neurological damage.

  • The “Deep Gluteal” Technique: It should be administered using a wide-bore needle (usually 21G) into the upper outer quadrant of the buttock to ensure it reaches the deep muscle.

  • Sensitivity Testing: Since the drug stays in the body for weeks, an allergic reaction can be prolonged and difficult to manage. A skin sensitivity test is mandatory before the first dose.

  • Jarisch-Herxheimer Reaction: When treating syphilis, patients may experience fever and chills within hours of the injection as the bacteria die off. This is a technical reaction to bacterial endotoxins, not an allergy.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Suspension Stability” USP: On your digital marketplace, highlight your Micronized Powder technology. Ensuring the particles are small enough to prevent needle blockage (clogging) while remaining large enough for sustained release is a high-level manufacturing achievement.

  • Procurement Strategy: This 1.2 MIU strength is the primary volume driver for UNICEF and WHO tenders in Africa and Southeast Asia.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Benzathine Penicillin G (0.6, 1.2, and 2.4 MIU) to support your registration in international B2B contracts.

Home

Posted on:

What is benzathine penicillin 2.4 used for?

Pharmaceutical Product Monograph: Benzathine Penicillin G (2.4 Million Units)

In the pharmaceutical industry, Benzathine Penicillin G (BPG) is a repository (long-acting) form of benzylpenicillin. As a pharmacist and manufacturer, I view this molecule as a “Sustained-Release Depot”—it is technically designed to provide low but consistent therapeutic blood levels for 2 to 4 weeks from a single intramuscular injection.

At your WHO-GMP facility in Mumbai, the 2.4 Million Units (2.4 MU) strength is the “High-Potency Standard” for treating systemic treponemal infections and providing long-term prophylaxis.

Therapeutic Profile: Primary Indications (2026 Guidelines)

The 2.4 MU dose is the specific clinical threshold required for adult treatment of syphilis and long-term rheumatic heart disease (RHD) management.

IndicationClinical ContextTechnical Rationale
Early SyphilisPrimary, Secondary, Early LatentSingle Dose: A one-time injection of 2.4 MU is the WHO gold standard for curing infectious syphilis.
Late/Unknown SyphilisTertiary or Late LatentTriple Dose: 2.4 MU administered once weekly for 3 consecutive weeks (Total: 7.2 MU).
Rheumatic FeverSecondary ProphylaxisPrevents recurrent Group A Strep infections that lead to Rheumatic Heart Disease.
Yaws, Bejel, PintaEndemic TreponematosesA single 2.4 MU dose (for adults) effectively eradicates these non-venereal skin diseases.
Congenital SyphilisMaternal TreatmentTreating the mother with 2.4 MU during pregnancy is the only technical way to prevent transmission to the fetus.

Mechanism: The “Slow-Motion” Bactericide

BPG works by creating a chemical reservoir in the muscle tissue:

Low Solubility: Benzathine penicillin is nearly insoluble in water. Once injected, it sits in the muscle as a “depot.”

Hydrolysis: It is slowly hydrolyzed (broken down) into active Benzylpenicillin (Penicillin G), which then enters the bloodstream.

 

Cell Wall Inhibition: Like all penicillins, it binds to Penicillin-Binding Proteins (PBPs), preventing bacterial cell wall synthesis and causing osmotic lysis.

 

Persistent Levels: Technically, a 2.4 MU dose maintains a blood concentration above $0.02 \text{ units/mL}$ for up to 21 days, which is higher than the MIC (Minimum Inhibitory Concentration) for Treponema pallidum.

The Pharmacist’s “Technical Warning”

  • STRICTLY INTRAMUSCULAR (IM): As a pharmacist, I must emphasize that BPG must never be given IV. Inadvertent intravenous injection causes “Embolia Cutis Medicamentosa” (Hoigné Syndrome) or immediate cardiac arrest and death.

  • The “Peanut Butter” Shot: Technically, this is a very thick (viscous) suspension. It requires a large-bore needle (18G or 21G). If the injection is too slow, the needle will “clog” as the suspension settles.

  • Jarisch-Herxheimer Reaction: When treating syphilis, patients may experience fever, chills, and headache within 2–12 hours. This is not an allergy; it is a reaction to the toxins released by dying bacteria.

  • Deep Gluteal Injection: It must be administered in the upper outer quadrant of the buttock (ventrogluteal site) to avoid the sciatic nerve.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Prefilled Syringe” USP: On your digital marketplace, highlight your Bicillin L-A style prefilled syringes. In international B2B markets, clinics prefer prefilled units because they eliminate the technical difficulty of reconstituting the thick powder without clogging.

  • Cold Chain Logistics: While “stable,” BPG suspension technically requires refrigeration ($2^\circ\text{C}$ to $8^\circ\text{C}$). If your facility produces the Dry Powder for Reconstitution, you have a major export advantage in Africa and SE Asia as it does not require a cold chain.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Benzathine Penicillin 1.2 MU and 2.4 MU to support your firm’s registration in international B2B tenders for sexual health and RHD programs.+

Home

 

Add to cart